Procter & Gamble acquired a number of other companies that diversified its product line and significantly increased profits. These acquisitions included Folgers Coffee, Norwich Eaton Pharmaceuticals (the makers of Pepto-Bismol), Richardson-Vicks, Noxell (Noxzema), Shulton's Old Spice, Max Factor, the Iams Company, ...
Multinational manufacturer of product ranges including family, personal and household care products.
Aug 24, 2009 ... The Procter & Gamble Company (NYSE: PG) and Warner Chilcott plc (Nasdaq: WCRX) today announced an agreement for the sale of P&G's global ... Credit Suisse Securities (USA) LLC, Barclays Capital Inc. and Citigroup Global Markets Inc. Procter & Gamble's financial advisor is Goldman Sachs and its ...
Sprout's flibanserin resubmission should have an easier time at FDA, as experts backed key aspects of trial design used in flibanserin studies and patients sought treatment options at last year's workshop on female sexual dysfunction. BioPharmaceutical Clinical Trials. Bookmark. 17 Feb 2015 ...
Procter & Gamble manufactures, markets and/or distributes more than 27 drugs in the U.S..
Learn about working at P&G Pharmaceuticals. Join LinkedIn today for free. See who you know at P&G Pharmaceuticals, leverage your professional network, and get hired.
Aug 23, 2009 ... Warner Chilcott Plc, a maker of contraceptives, said it will buy Procter & Gamble Co's pharmaceuticals business for $3.1 billion in a deal that will immediately boost profits and produce tax advantages for years to come, lifting its shares 27 percent.
Aug 24, 2009 ... After struggling to gain a toehold in the pharmaceutical business, Procter & Gamble has finally decided to give up. The company announced on Monday that it would sell its global pharmaceutical business to the Irish drug maker Warner Chilcott for $3.1 billion, ending two decades of setbacks and missteps.